ConductScience.org, home

Paper41246002

bla IMP-45 Amplification Facilitates Heterogeneous Resistance to Imipenem in Pseudomonas aeruginosa.

Du Y and 7 others. Infect Drug Resist, 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. bla IMP-45 Amplification Facilitates Heterogeneous Resistance to Imipenem in Pseudomonas aeruginosa. Papers, record 41246002. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41246002

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
bla IMP-45 Amplification Facilitates Heterogeneous Resistance to Imipenem in Pseudomonas aeruginosa.
PubMed
Journal
Infect Drug Resist
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2025-11-20
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Du YYiyao
2Yuan MMin
3Su ZZhedi
4Liu ZZhiguo
5Qiu XXiaotong
6Xu SShuaihttps://orcid.org/0000-0002-8686-0268
7Zhu XXiong
8Li ZZhenjun

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139234777Characterization of the Chromosomally Located Metallo-β-Lactamase Genes blaIMP-45 and blaVIM-2 in a Carbapenem-Resistant Pseudomonas aeruginosa Clinical Isolate.Microb Drug Resist2024https://conductscience.org/library/papers/39234777PubMed
28787889Serum bactericidal activities and comparative pharmacokinetics of meropenem and imipenem-cilastatin.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8787889PubMed
339303871The frequency of AmpC overproduction, OprD downregulation and OprM efflux pump expression in Pseudomonas aeruginosa: A comprehensive meta-analysis.J Glob Antimicrob Resist2024https://conductscience.org/library/papers/39303871PubMed
438730266Three concurrent mechanisms generate gene copy number variation and transient antibiotic heteroresistance.Nat Commun2024https://conductscience.org/library/papers/38730266PubMed
520110294Acquisition of multidrug resistance transposon Tn6061 and IS6100-mediated large chromosomal inversions in Pseudomonas aeruginosa clinical isolates.Microbiology (Reading)2010https://conductscience.org/library/papers/20110294PubMed
635572664Molecular Mechanism of the β-Lactamase Mediated β-Lactam Antibiotic Resistance of Pseudomonas aeruginosa Isolated From a Chinese Teaching Hospital.Front Microbiol2022https://conductscience.org/library/papers/35572664PubMed
739079540WHO publishes updated list of bacterial priority pathogens.Lancet Microbe2024https://conductscience.org/library/papers/39079540PubMed
839500066Multidrug-resistant bacteria quorum-sensing inhibitors: A particular focus on Pseudomonasaeruginosa.Eur J Med Chem2025https://conductscience.org/library/papers/39500066PubMed
937879457Characterization of a novel Tn6485h transposon carrying both blaIMP-45 and blaAFM-1 integrated into the IncP-2 plasmid in a carbapenem-resistant Pseudomonas aeruginosa.J Glob Antimicrob Resist2023https://conductscience.org/library/papers/37879457PubMed
1023716048Complete sequence of pOZ176, a 500-kilobase IncP-2 plasmid encoding IMP-9-mediated carbapenem resistance, from outbreak isolate Pseudomonas aeruginosa 96.Antimicrob Agents Chemother2013https://conductscience.org/library/papers/23716048PubMed
1139301190Molecular epidemiology and carbapenem resistance mechanisms of Pseudomonas aeruginosa isolated from a hospital in Fujian, China.Front Microbiol2024https://conductscience.org/library/papers/39301190PubMed
1236651737An XDR Pseudomonas aeruginosa ST463 Strain with an IncP-2 Plasmid Containing a Novel Transposon Tn6485f Encoding blaIMP-45 and blaAFM-1 and a Second Plasmid with Two Copies of blaKPC-2.Microbiol Spectr2023https://conductscience.org/library/papers/36651737PubMed
1332243918Genomic characterisation of clinical Pseudomonas aeruginosa isolate PAG5 with a multidrug-resistant megaplasmid from China.J Glob Antimicrob Resist2020https://conductscience.org/library/papers/32243918PubMed
1438515868Rates of resistance and heteroresistance to newer β-lactam/β-lactamase inhibitors for carbapenem-resistant Enterobacterales.JAC Antimicrob Resist2024https://conductscience.org/library/papers/38515868PubMed
1538616963Characteristics and phylogenetic distribution of megaplasmids and prediction of a putative chromid in Pseudomonas aeruginosa.Comput Struct Biotechnol J2024https://conductscience.org/library/papers/38616963PubMed
1639253335Frequency of cefiderocol heteroresistance among patients treated with cefiderocol for carbapenem-resistant Acinetobacter baumannii infections.JAC Antimicrob Resist2024https://conductscience.org/library/papers/39253335PubMed
1737457958
Optimal treatment of ceftazidime-avibactam and aztreonam-avibactam against bloodstream infections or lower respiratory tract infections caused by extensively drug-resistant or pan drug-resistant (XDR/PDR) Pseudomonas aeruginosa.
Front Cell Infect Microbiol2023https://conductscience.org/library/papers/37457958PubMed
1833620296An IncP-2 plasmid sublineage associated with dissemination of blaIMP-45 among carbapenem-resistant Pseudomonas aeruginosa.Emerg Microbes Infect2021https://conductscience.org/library/papers/33620296PubMed
1924777897IMP-45-producing multidrug-resistant Pseudomonas aeruginosa of canine origin.J Antimicrob Chemother2014https://conductscience.org/library/papers/24777897PubMed
2031211681Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015.Emerg Infect Dis2019https://conductscience.org/library/papers/31211681PubMed

See all 38 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42045833Genomic characterization of the multidrug-resistant IncP-2 plasmid pPAMS in a clinical isolate Pseudomonas aeruginosa.BMC Microbiol2026https://conductscience.org/library/papers/42045833

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41246002

GET https://conductscience.org/api/papers/v1/41246002/references?page=2